Stevanato Group (NYSE:STVN) Stock Rating Upgraded by TD Cowen

Stevanato Group (NYSE:STVN) was upgraded by investment analysts at TD Cowen to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports.

Other equities research analysts have also issued reports about the stock. Wolfe Research began coverage on shares of Stevanato Group in a research report on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 price objective on the stock. Weiss Ratings restated a “sell (d+)” rating on shares of Stevanato Group in a research report on Monday, June 8th. Morgan Stanley lowered their price target on shares of Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Friday, March 6th. KeyCorp dropped their price objective on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday, March 5th. Finally, Citigroup dropped their price objective on shares of Stevanato Group from $32.00 to $26.00 and set a “buy” rating for the company in a research note on Thursday, March 5th. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Stevanato Group has an average rating of “Moderate Buy”.

Stevanato Group Price Performance

STVN stock opened at €17.63 on Wednesday. The firm has a 50 day moving average of €17.06 and a 200-day moving average of €17.44. The company has a market cap of $5.34 billion, a price-to-earnings ratio of 29.88, a PEG ratio of 1.57 and a beta of 0.78. The company has a current ratio of 1.63, a quick ratio of 1.11 and a debt-to-equity ratio of 0.21. Stevanato Group has a 12-month low of €12.89 and a 12-month high of €28.00.

Stevanato Group (NYSE:STVN) last released its quarterly earnings results on Friday, May 8th. The company reported €0.11 earnings per share for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). The firm had revenue of €273.57 million during the quarter. Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.Stevanato Group’s revenue for the quarter was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.10 EPS. As a group, equities analysts expect that Stevanato Group will post 0.68 EPS for the current fiscal year.

Institutional Investors Weigh In On Stevanato Group

Hedge funds have recently modified their holdings of the company. GW&K Investment Management LLC boosted its stake in shares of Stevanato Group by 76.2% during the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after purchasing an additional 1,055 shares during the last quarter. Fifth Third Bancorp raised its position in shares of Stevanato Group by 22.6% in the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock valued at $58,000 after buying an additional 773 shares during the last quarter. State of Wyoming lifted its stake in shares of Stevanato Group by 39,216.7% during the second quarter. State of Wyoming now owns 2,359 shares of the company’s stock valued at $58,000 after buying an additional 2,353 shares during the period. Quantbot Technologies LP purchased a new position in shares of Stevanato Group during the third quarter valued at approximately $68,000. Finally, Tower Research Capital LLC TRC boosted its position in Stevanato Group by 1,268.7% during the second quarter. Tower Research Capital LLC TRC now owns 4,585 shares of the company’s stock worth $112,000 after acquiring an additional 4,250 shares during the last quarter.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.